Zhicheng Lin
Affiliations: | NEPRC Psychiatry | Harvard Medical School, Boston, MA, United States |
Google:
"Zhicheng Lin"Mean distance: (not calculated yet)
Collaborators
Sign in to add collaborator| Bertha Madras | collaborator | 2005-2006 | Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hasbi A, Madras BK, Bergman J, et al. (2019) Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons. Iscience. 23: 100794 |
| Canseco-Alba A, Schanz N, Sanabria B, et al. (2018) Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons. Behavioural Brain Research |
| Liu QR, Canseco-Alba A, Zhang HY, et al. (2017) Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. Scientific Reports. 7: 17410 |
| Sheng Y, Filichia E, Shick E, et al. (2016) Lower Dopamine D2 Receptor Expression Levels in Human Dopaminergic Neurons Derived From Opioid-Dependent iPSCs. The American Journal of Psychiatry. 173: 429-431 |
| Zhao Y, Zhou Y, Xiong N, et al. (2012) Identification of an intronic cis-acting element in the human dopamine transporter gene. Molecular Biology Reports. 39: 5393-9 |
| Xiong N, Xiong J, Khare G, et al. (2011) Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease. Plos One. 6: e20677 |
| Madras BK, Fahey MA, Goulet M, et al. (2006) Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo. The Journal of Pharmacology and Experimental Therapeutics. 319: 570-85 |
| Madras BK, Xie Z, Lin Z, et al. (2006) Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. The Journal of Pharmacology and Experimental Therapeutics. 319: 561-9 |
| Dohi T, Kitayama S, Morioka N, et al. (2004) Regulation of dopamine and MPP+ transport by catecholamine transporters. Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 24: 43-7 |
| Lin Z, Uhl GR. (2003) Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities. The Pharmacogenomics Journal. 3: 159-68 |